Treatment patterns in patients with mantle cell lymphoma: Updated report of the Asia-Pacific multinational retrospective registry study

被引：0

作者：

Yoon, D. H. ^{[1
]}

Cho, H. ^{[2
]}

Sheng, J. C. Y. ^{[3
]}

Kim, D. J. ^{[4
]}

Kang, K-W. ^{[5
]}

Kwak, J-Y. ^{[6
]}

Tan, S-M. ^{[7
]}

Lee, J-O. ^{[8
]}

Oh, S. Y. ^{[9
]}

Eom, H-S. ^{[10
]}

Do, Y. R. ^{[11
]}

Jeong, S. H. ^{[12
]}

Kang, H. J. ^{[13
]}

Koh, Y. ^{[14
]}

Bunworasate, U. ^{[15
]}

Kim, H. J. ^{[16
]}

Jo, J-C. ^{[17
]}

Kim, S-H. ^{[18
]}

Kato, K. ^{[19
]}

Kim, W. S. ^{[20
]}

机构：

[1] Univ Ulsan, Oncol, Coll Med, Seoul, South Korea

[2] Univ Ulsan, Asan Med Ctr, Coll Med, Dept Oncol, Seoul, South Korea

[3] NCCS Natl Canc Ctr Singapore, Med Oncol Dept, Singapore, Singapore

[4] Kosin Univ, Gospel Hosp, Dept Internal Med, Busan, South Korea

[5] Korea Univ, Dept Internal Med, Anam Hosp, Seoul, South Korea

[6] Chonbuk Natl Univ Hosp, Dept Internal Med, Jeonju, South Korea

[7] Hosp Ampang, Dept Hematol, Ampang Jaya, Malaysia

[8] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Div Hematooncol, Seongnam, South Korea

[9] Dong A Univ, Coll Med, Internal Med Dept, Busan, South Korea

[10] Natl Canc Ctr Hosp, Ctr Hematol Malignancies, Goyang, South Korea

[11] Keimyung Univ, Sch Med, Dongsan Med Ctr DSMC, Dept Med, Daegu, South Korea

[12] Ajou Univ, Dept Hematol Oncol, Sch Med, Suwon, South Korea

[13] Korea Canc Ctr Hosp, Radiat Oncol Dept, Seoul, South Korea

[14] SNUH Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea

[15] Chulalongkorn Univ, Dept Med, Div Hematol, Fac Med, Bangkok, Thailand

[16] HUMC Hallym Univ, Dept Internal Med, Sacred Heart Hosp HUSHH, Anyang, South Korea

[17] Asan Med Ctr, Dept Hematol & Oncol, Asan Inst Life Sci, Seoul, South Korea

[18] Soonchunhyang Univ, Bucheon Hosp, Dept Internal Med, Bucheon, South Korea

[19] Kyushu Univ Hosp, Dept Hematol, Fukuoka, Japan

[20] Samsung Med Ctr SMC, Dept Med, Seoul, South Korea

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.10.448

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

333MO

引用

页码：S1600 / S1601

页数：2

共 50 条

[41] Initial Treatment Patterns and Survival Outcomes of Mantle Cell Lymphoma Patients in China in the Rituximab Era
Li, Yun
Wu, Meng
Huang, Huiqiang
Xu, Wei
Huang, Haiwen
Zhao, Weili
Wang, Yanyan
Liu, Shuo
Xu, Pengpeng
Chen, Zhengming
Song, Yuqin
Ruan, Jia
Wu, Depei
BLOOD, 2019, 134
[42] Real-World Characteristics, Treatment Patterns, and Outcomes of Patients with Mantle Cell Lymphoma By LOT
Sineshaw, Helmneh M.
Bai, Claire
De Nigris, Enrico
Prescott, Jennifer
Ogbu, Uzor C.
Zettler, Christina M.
Fernandes, Laura L.
Wang, Ching-Kun
BLOOD, 2024, 144 : 6279 - 6280
[43] PATIENT CHARACTERISTICS AND TREATMENT PATTERNS IN PATIENTS WITH MANTLE CELL LYMPHOMA IN CHINA: A REAL-WORLD, CONTEMPORARY COHORT STUDY
Liu, Y.
Bao, Y.
Chen, Y.
Zhou, J.
VALUE IN HEALTH, 2024, 27 (06) : S162 - S162
[44] Treatment patterns and clinical outcomes of mantle cell lymphoma: a retrospective cohort study by CHOICE (Jun, 10.1002/ijc.34619, 2023)
Zeng, Dongfeng
Fang, Yu
Fei, Yue
Liang, Rong
Ye, Haige
Liang, Yun
Sun, Xiuhua
Wang, Michael
Huang, Huiqiang
Qiu, Lugui
Che, Yuxuan
Liu, Panpan
Wang, Yi
Pan, Tao
Lv, Yao
Deng, Jintai
Yi, Shuhua
He, Yizi
Xiao, Ling
Lv, Huijuan
Feng, Jiangfang
Zhang, Huilai
Zhou, Hui
Zou, Dehui
Cai, Qingqing
INTERNATIONAL JOURNAL OF CANCER, 2023, 153 (06) : E4 - E5
[45] Outcome of COVID-19 in Patients With Mantle Cell Lymphoma-Report From the European MCL Registry
Tilch, Marie-Kristin
Visco, Carlo
Kinda, Sandra
Hermine, Olivier
Kohn, Milena
Besson, Caroline
Lamure, Sylvain
Dulery, Remy
Ragaini, Simone
Eyre, Toby A.
Van Meerten, Tom
Ohler, Anke
Eckerle, Steffen
Dreyling, Martin
Hess, Georg
Gine, Eva
da Silva, Maria Gomes
HEMASPHERE, 2022, 6 (05): : E0711
[46] Rituximab/bendamustine/cytarabine for transplant-eligible patients with mantle cell lymphoma: A retrospective study
Shimizu, Yuki
Kaji, Daisuke
Watanabe, Otoya
Yamaguchi, Kyosuke
Kageyama, Kosei
Taya, Yuki
Nishida, Aya
Ishiwata, Kazuya
Takagi, Shinsuke
Yamamoto, Hisashi
Mori, Yuki-Asano
Wake, Atsushi
Uchida, Naoyuki
Taniguchi, Shuichi
Yamamoto, Go
CANCER MEDICINE, 2023, 12 (11): : 12548 - 12552
[47] Mantle cell lymphoma: a retrospective study on 27 patients. Clinical features and natural history
Bertini, M
Rus, C
Freilone, R
Botto, B
Calvi, R
Novero, D
Orsucci, L
Vitolo, U
Palestro, G
Resegotti, L
HAEMATOLOGICA, 1998, 83 (04) : 312 - 316
[48] Treatment patterns and outcomes with subcutaneous bortezomib in patients with relapsed mantle cell lymphoma: a retrospective, observational study of patient medical records from US community oncology practices
Skarbnik, Alan P.
Ma, Esprit
Lafeuille, Marie-Helene
Fortier, Jonathan
Feldman, Tatyana
Duh, Mei Sheng
van de Velde, Helgi
Niculescu, Liviu
Bonthapally, Vijayveer
Goy, Andre
LEUKEMIA & LYMPHOMA, 2017, 58 (08) : 1968 - 1972
[49] Subcutaneous (SQ) Bortezomib (BTZ) in Patients (Pts) with Relapsed Mantle Cell Lymphoma (MCL): Retrospective, Observational Study of Treatment Patterns and Outcomes in US Community Oncology Practices
Skarbnik, Alan P.
Ma, Esprit
Lafeuille, Marie-Helene
Fortier, Jonathan
Feldman, Tatyana
Duh, Mei Sheng
Ng, Yvette
van de Velde, Helgi
Dow, Edward
Niculescu, Liviu
Bonthapally, Vijayveer
Goy, Andre
BLOOD, 2014, 124 (21)
[50] TREATMENT AND PROGNOSIS OF CENTROCYTIC (MANTLE CELL) LYMPHOMA - A RETROSPECTIVE ANALYSIS OF 26 PATIENTS TREATED IN ONE INSTITUTION
ZUCCA, E
FONTANA, S
ROGGERO, E
PEDRINIS, E
PAMPALLONA, S
CAVALLI, F
LEUKEMIA & LYMPHOMA, 1994, 13 (1-2) : 105 - 110

← 1 2 3 4 5 →